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1The implantable cardioverter-defibrillator (ICD) is the established therapy for the primary or secondary prophy-
laxis of sudden cardiac death in people with a wide range of 
cardiac pathologies.1–4 Regardless of the treatment of their 
underlying cardiac condition, people who require an ICD 
must adapt to living with a unique and complex device.5 There 
is substantial evidence about the prevalence of psychological 
distress,6,7 and differences between the experiences of men and 
women have been reported.8 Little is known about changes in 
social health, the capacity to fulfil social roles, responsibili-
ties, and other functions of daily life.9 Previous research has 
reported diminished social interactions and social avoidance 
behavior,10,11 disruption to employment, exercise and sexual 
activity,12,13 and difficulties with parenting and other caregiving 
responsibilities.14,15 Limited evidence suggests that sex differ-
ences may exist in the trajectory of social health,8 an important 
dimension of quality of life (QOL). The assessment of QOL 
is gaining clinical value as an indicator of patients’ perspec-
tive on treatment, recovery, and outcomes.16 In addition, pro-
viding clinicians with QOL information has been shown to 
improve clinician–patient communication, raise awarenevss 
of problems that would otherwise be unidentified, improve 
care plans, and enhance multidisciplinary collaboration.17,18
The purpose of the study was to investigate changes in social 
health in the first 6 months after ICD implantation. Social health 
encompasses the ability to engage in social roles (physically and 
emotionally), social functioning, and satisfaction with social 
roles and activities. The conceptualization of social health was 
grounded in the health-related QOL model proposed by Wilson 
and Cleary.19 The model is applicable to clinical research20 and 
has been widely applied to different patient populations.21 We 
aimed to describe the change, if any, in self-reported social 
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health, and to determine whether differences in the pattern of 
change could be predicted by a set of theoretically derived vari-
ables, including sex. We hypothesized that different variables 
were associated with change between measurement time points, 
and within the study cohort. To this end, the unique analytic 
interest was to explore the participants’ individual trajectories 
of change (ie, change within the same person measured at sev-
eral intervals), and across groups of people.
We differentiated a priori between the experiences of men 
and women in an effort to contribute to clinicians’ awareness 
of the effect of sex on the early recovery after ICD and sup-
porting the planning of follow-up interventions. In addition, 
the study was conducted with an interest in other candidate 
predictor variables drawn from current research, raised by the 
interdisciplinary clinical team, and consistent with the con-
ceptual framework underpinning the study. These included 
indication for implantation (ie, primary and secondary), age, 
social support (ie, marital status), employment status, and the 
travel distance to specialized medical care given the unique 
constraints of Canadian geography. We further explored 
the relationship between the urgency of implantation, self-
reported ICD shocks, and the experience of on-going cardio-
vascular symptoms.
Methods
Study Design and Sampling Frame
The study involved a prospective, longitudinal design. A consecutive 
series of adult patients implanted with a first ICD completed a set of 
standardized and validated questionnaires before implantation, and 1, 
2, and 6 months after receiving the device. The time intervals were se-
lected to focus on the early adaptation period, a potentially vulnerable 
period, which remains poorly described in the current literature, and 
which is amenable to timed and targeted interdisciplinary interven-
tions to improve outcomes. Study participants were given the choice 
of completing the questionnaires using a paper- or Web-based format, 
which contained identical text and were intentionally visually similar.
Between April 2010 and June 2011, 308 consecutive elective and 
inpatients referred for their first ICD for primary or secondary pre-
vention at a hospital in western Canada were screened for eligibility. 
Patients who received an ICD with cardiac resynchronization therapy 
function, were <18 years old, did not speak English, were unable to 
complete a written questionnaire, or did not provide informed con-
sent were excluded. The study was approved by the institutional re-
view committee (Providence Healthcare Research Ethics Board), and 
subjects provided informed consent. 
Measures
Demographic and Clinical Variables
Demographic and clinical information was obtained with 
a baseline questionnaire (ie, before ICD implantation). The 
demographic and clinical variables included sex, age, New 
York Heart Association functional classification, previous car-
diac revascularization (ie, percutaneous coronary intervention 
or coronary artery bypass graft surgery), coexisting condi-
tions, left ventricular ejection fraction, urgency (ie, inpatient 
or elective outpatient), indication for implantation (ie, primary 
or secondary), and self-reported ICD shock history. To capture 
additional indicators associated with social function, marital 
status and employment status were recorded. Information was 
obtained from the participants’ medical records.
Social Health
Three subscales of the SF-36v2, a generic health profile ques-
tionnaire with 36 items that measure 8 health domains, were 
used to measure social health: the 4-item role physical, the 
2-item role emotional, and the 2-item social functioning sub-
scales.22 These subscales measure the extent to which physical
health or emotional problems interfere with people’s normal
social activities and their capacity to perform their work or
other regular daily activities, including accomplishing less
than wanted, not doing work as carefully as usual, or reducing
the amount of time spent on activities. Psychometric evalu-
ation of the subscales has demonstrated that they perform
similarly with average interitem correlation coefficients of
0.57 (role physical), 0.61 (role emotional), and 0.74 (social
functioning) and with Cronbach α coefficients of 0.84, 0.83,
and 0.85, respectively.23 There is limited psychometric evalu-
ation of the SF-36v2 subscales in the ICD population. In our
data, the Cronbach α coefficients were evaluated at each mea-
surement cycle, and were 0.94 for role physical (mean inter-
item correlation range: 0.79–0.82 across repeated measures),
between 0.91 and 0.93 for role emotional (mean interitem
correlation range: 0.77–0.82), and between 0.80 and 0.90 for
social functioning (mean interitem correlation range: 0.66–
0.82). The measurement equivalence and construct validity
across sex of the SF-36 has been studied and confirmed in
multiple populations, clinical settings, and languages.24
The use of the SF-36v2 is proprietary and licensed through 
QualityMetrics, which provides proprietary statistical analy-
sis. To facilitate data analysis, we used the QualityMetrics 
Health Outcomes Scoring Software 4.0 User’s Guide to 
develop IBM SPSS 19 syntax to recode and recalibrate 
the items as required, and to duplicate the scoring for each 
subscale.25
WHAT IS KNOWN
• The implantable cardioverter defibrillator can be
associated with changes in quality of life. Significant
emphasis has been placed on the study of changes
in mental health, especially anxiety and depression
associated with implantable cardioverter defibrilla-
tor shocks.
• Social health is an important dimension of quality
of life.
WHAT THE STUDY ADDS
• We found that social health improves in the first 6
months after implantable cardioverter defibrilla-
tor but men and women differ in their trajectory of
change. Men’s mean scores were higher than wom-
en’s before implantation, but women improved at a
faster rate in the first 6 months.
• Individual growth modeling provides novel analytic
tools to study between- and within-group variation in 
change parameters and can inform clinical practice.
3Satisfaction With Social Roles and Discretionary 
Social Activities
In collaboration with the US National Institutes of Health 
Roadmap for Medical Research Initiative, the Patient-Reported 
Outcomes Measurement Information System (PROMIS) is a 
collaborative effort of outcomes scientists that was initiated 
in 2004 to transform the selection and use of patient-reported 
outcome measurements in clinical research and practice 
evaluation. To develop item banks, the PROMIS researchers 
conducted a series of standardized item development phases.26 
PROMIS short forms were developed from large item banks. 
The findings of an extensive comparison with the overall 
bank and other well validated and widely accepted standard 
measures provide evidence of good reliability across sex and 
across the score distributions of these short forms.9,27 How-
ever, there is no psychometric evidence specific to the ICD 
population; this study is the first to use selected PROMIS short 
forms to augment the study of social health in patients with 
ICDs to measure domains that can inform clinical practice and 
interdisciplinary follow-up programs.
The satisfaction with participation in social roles short-
form measures people’s satisfaction with their ability to do 
things with their family, meet the needs of their dependents, 
perform daily routines, run errands, work, and perform house-
hold chores. The satisfaction with discretionary social activi-
ties short form focuses on the ability to “do things for fun at 
home,” “do things for… friends,” “do leisure activities,” and 
satisfaction with “current level of activities of activities with 
friends” and “level of social activities.” Each short form con-
tains 7 items and is correlated at 0.99 with its respective full-
item bank.9 When correlated with items of the SF-36v2 role 
physical, role emotional, and social functioning subscales, 
the 2 PROMIS instruments produced moderately sized cor-
relations ranging from 0.44 to 0.59. This may indicate that 
the PROMIS short forms broaden the measurement of social 
health by measuring additional aspects of social functioning 
that are not fully captured in the SF-36.9
Device Acceptance
The Florida patient acceptance survey was developed from an 
original bank of 47 items identified through literature reviews, 
surveys, and interviews with clinicians and patients.28 Device 
acceptance refers to the psychological accommodation to liv-
ing with an ICD and the derivation of biomedical, psychologi-
cal, and social functioning.28 Higher scores indicate greater 
device acceptance. After initial validation and factor analysis, 
a 15-item scale was developed. Recent confirmatory analysis 
recommended the removal of 3 items to improve the instru-
ment’s performance, with reported Cronbach α coefficient 
ranging from 0.76 to 0.82.29 We conducted our analyses using 
the summed scores of the 12-item instrument. We obtained a 
Cronbach α coefficient ranging from 0.84 to 0.88, with mean 
interitem correlation coefficients ranging from 0.32 to 0.39 for 
the 12-item scale, over repeated measures.
Statistical Analyses
We used the IBM SPSS19 (Armonk, NY) program to conduct 
the analyses. Descriptive statistics were used to report demo-
graphic and clinical characteristics of the sample. To facilitate 
the interpretation of the findings, the scores of all scales 
were rescaled to a standardized 0 to 100 possible range and 
the directionality of the scales was maintained. Missing data 
accounted for <2% of the total data. A single imputation pro-
cedure using the expectation maximization algorithm (IBM 
SPSS 19 Missing Value Analysis module) was performed to 
impute values for missing data at the item level before con-
structing the summed scale scores.
After recommendations by Heck,30 we used an individual 
growth modeling approach to evaluate temporal change and 
differences in change trajectories by general. The use of indi-
vidual growth modeling is a relatively new, powerful, and flex-
ible approach that allows the use of all available data to analyze 
the interaction effects between time and other between-subject 
factors, and cross-level interactions (eg, the effects of between-
subject variables on individual growth trajectories), and to esti-
mate regression parameters from the individual growth models 
by treating the intercepts and slopes as random effects.31,32 The 
focus is not whether there are differences in the between- and 
within-subjects’ levels of a factor, but the extent to which the vari-
ance of the responses is influenced by this factor compared with 
the total variability of the data. Individual growth models provide 
relatively precise estimates of individual growth over time and 
greater statistical power to detect predictors of individual differ-
ences in change, even with relatively small samples and varia-
tion in the number and spacing of measurements.33 The modeling 
technique allows for the study of both intra- and interindividual 
differences in the change parameters thus exploring the patterns 
of change and the effects at both the individual and the group 
levels, whereas estimating the change parameter with greater 
precision when the number of time waves is >2. This improves 
the reliability of the change parameters by reducing the SE of 
the within-subject change in the parameter estimates. The growth 
parameters include (1) intercepts, which pertain to starting point 
of the slope (or the value of the outcome variable at baseline), and 
(2) slopes, which represent the rates of change (we included both
a linear component and a quadratic component to fit nonlinear
curves). Individual growth models are more powerful than other
methods in examining the effects associated with repeated mea-
sures because they model the covariance matrix (ie, fitting the
true covariance structure to the data, rather than imposing a cer-
tain type of structure). The aim of the study’s individual growth
models development was to find models that used the least num-
ber of parameters while providing the best fit.32,33
The analytic approach, as recommend by Heck,30 involved 
3 steps. We first produced univariate descriptive change sta-
tistics of the 6 scales. We selected a threshold of 10% and a 
distribution-based 0.30 SD criterion as a meaningful indica-
tor of the minimally important difference based on the rec-
ommendation provided by Osoba21 that a change of 10% of 
the scale breadth (possible range) be taken as representing a 
definite change that is perceptible to patients (p. 9). In the sec-
ond step, we constructed an unconditional individual growth 
model using the Linear Mixed Models program in IBM SPSS 
19, which assumes that the outcome variable (ie, each selected 
scale) is linearly related to the fixed factors, random factors, 
and the covariates entered in a model. The aim was to estimate 
individual change over time and determine the most plausible 
shape of the change curves, and explore whether individual 
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differences in change curves are random or systematic. The 
latter is determined by evaluating the statistical significance 
in residual variability of the growth parameters (notably, the 
slopes).31,33 Finally, having found systematic differences in 
individual change curves, the third step involved specifying a 
conditional model to test whether these differences could be 
explained by sex and other key covariates of interest derived 
from the current literature and of clinical interest to the inter-
disciplinary research team. These included age, indication for 
implantation, urgency, shock history, marital status, household 
size, employment status, and distance to electrophysiology 
services. This is done by examining whether these variables 
explain the residual variances in the rates of the participants’ 
change.31,34,35
Results
Sample
There were 308 consecutive patients screened for study inclu-
sion. The final sample consisted of 171 (74.0%) of the 231 
eligible participants. Baseline measurements were obtained 
before device implant (median time=5.8 days). Follow-up 
measurements were conducted at 1 (n=149; 87.1%), 2 (n=140; 
81.9%), and 6 (n=139; 81.3%) months after implantation 
either by means of a mailed paper questionnaire (68.4%) or 
a web-based format (31.6%). The flow chart of participant 
recruitment and retention is presented in Figure 1.
The sample consisted of 128 men (74.9%). The partici-
pants ranged in age from 18 to 81 years (mean=58.7 years; 
SD=14.5). Because of the vast geography of the catchment 
area, 61 (35.7%) participants were required to travel >100 km 
to obtain specialized medical care. At the time of their ICD 
implantation, 99 participants (57.9%) underwent a same-day 
admission and discharge elective procedure, whereas 72 par-
ticipants (42.1%) were inpatients at the implanting center or 
transferred by ambulance from a referring community hospital. 
Most participants (65.5%) had a primary indication for an ICD. 
The self-reported prevalence rates of having had ≥1 ICD shock 
in the first month after implantation were 6.7% (n=10) within 
1 month, 4.3% (n=6) between the first and second months, and 
2.9% (n=4) between the second and sixth months (Table 1).
Step 1: Grouped Data—Presence and Direction of 
Change
The scores of the 6 indicators of social health improved with 
time. For the 3 SF-36v2 subscales, the absolute differences in 
mean scores between the first and last measurement occasions 
were 15.8 points on the 100-point scale for role physical, 7.3 
for role emotional, and 14.3 for social functioning, whereas 
the relative percentage changes in these scores were 35.3%, 
11.6%, and 23.7%, respectively. The 2 PROMIS short-form 
measures of social health exhibited similar changes with an 
absolute change in mean scores between the first and last mea-
surement occasions of 16.4 points for satisfaction with par-
ticipation in social roles, and 11.9 points for satisfaction with 
participation in discretionary social activities, which were 
relative improvements of 33.3% and 23.5%, respectively. The 
Figure 1. Flow chart of participant recruitment and 
retention.
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between the first and second months, and remained consistent 
at the 6-month measurement. The percentage change between 
the first and last measure was 6.9%. The distributions and pat-
terns of change for the social health measures are presented 
in Table 2. According to the benchmarks delineated by Wyr-
wich,36 the magnitude of change, with respect to what would 
be considered a minimally important difference, was moder-
ate to large or large.
Step 2: Unconditional Model—Variation in 
Individual Change
The participants demonstrated improvements in their social 
health over time. The rate of change was statistically sig-
nificant for the SF-36v2 role emotional (6.4 points over each 
observation), SF-36v2 social functioning (7.7 points over each 
observation), satisfaction with participation in social roles 
(6.2 points over each observation), satisfaction with partici-
pation in discretionary social activities (7.3 points over each 
observation), and patient acceptance of implantable cardiac 
device therapy (2.3 points over each observation) subscales.
Using an unstructured covariance matrix for all the mod-
els, we found that there was statistically significant individ-
ual variability in the linear rates of change for SF-36v2 role 
emotional, SF-36v2 social functioning, satisfaction with par-
ticipation in social roles, and satisfaction with participation in 
discretionary social activities. However, an unstructured cova-
riance matrix resulted in a model that failed to converge with 
1000 iterations for the SF-36v2 role physical subscale, and 
thus the covariance parameters, and their corresponding test 
statistics and confidence intervals could not be computed. To 
address this issue, we specified a diagonal covariance matrix 
and were able to reach convergence, albeit with extremely 
wide confidence intervals.
At level 1 (within participants), there was a statistically sig-
nificant residual variability noted in the average participant’s 
score around her or his trajectory for the 6 social health mea-
sures. The models for SF-36v2 role emotional, SF-36v2 social 
functioning, satisfaction with participation in social roles, and 
satisfaction with participation in discretionary social activi-
ties all displayed evidence of variability in the rates of change 
(Table I in the Data Supplement).
In examining the level 2 (between participants) residuals, 
we also noted that the initial status (baseline) and growth rates 
were correlated for satisfaction with participation in discre-
tionary social activities. The identification of individual tra-
jectories of change warranted further model development to 
explore the effects of the selected predictors.
Step 3: Conditional Model—Time-Predictor 
Interaction Effects and Individual Trajectories of 
Change
Regardless of the variance of the intercepts, men and women 
differed significantly in their rates of change in the scores of 
SF-36v2 social functioning, satisfaction with participation 
in social roles, and satisfaction with participation in discre-
tionary social activities. The different trajectories of men 
and women showed a similar pattern of change with women 
exhibiting worse social health status at baseline, experiencing 
a faster rate of change or improvement during the 6 months 
of follow-up, and achieving scores that exceeded the men’s 
scores at the end of the observation period (Figure 2). The 
disparity in the absolute mean differences between the scores 
at baseline and at the 6-month follow-up ranged between 8.1 
and 11.6 points for men, and 20.5 and 23.9 points for women. 
Although men’s mean scores exceeded women’s mean scores 
on all indicators at baseline (range of absolute mean differ-
ence: 7.0–9.6 points), the rate of change of women resulted 
in a reversal in standing at 6 months after implantation, with 
the mean score of women exceeding the men’s by 2.8 to 4.1 
(Table 3; Figure 3).
In addition to the identification of the sex-based differences 
in the participants’ temporal changes in their social health 
indicators, we found some other salient subgroup trajectories 
of change. The participants that received their implant on an 
urgent inpatient basis had lower scores of the SF-36v2 social 
functioning subscale at baseline, but improved more rapidly 
and crossed over to reporting better scores compared with the 
relatively more medically stable elective outpatients. Marital 
status differentiated the change trajectories associated with 
Table 1. Patient Characteristics by Sex
Characteristic
Women
n=43 
(25.1%)
Men
n=128 
(74.9%) P Value
All
n=171  
(100%)
n (%) n (%) n (%)
Age, mean(SD) 58.7 (14.5) 62.0 (13.4) 0.17 61.2 (13.7)
Primary indication 25 (58.1) 89 (69.5) 0.17 114 (66.7)
NYHA Classification
 I 15 (34.9) 25 (19.5) 0.04 40 (23.4)
 II 10 (23.3) 57 (44.5) 0.01 67 (39.2)
 III 10 (23.3) 33 (25.8) 0.74 43 (25.1)
 Unknown 8 (18.6) 13 (10.2) 0.15 21 (12.3)
Coronary artery disease 16 (37.2) 78 (60.9) 0.01 94 (55.0)
Percutaneous coronary 
intervention
11 (25.6) 39 (30.5) 0.55 50 (29.2)
Cardiac surgery 7 (16.3) 47 (36.7) 0.01 54 (31.6)
Myocardial infarction 9 (20.9) 56 (43.8) 0.01 65 (38.0)
Previous cardiac arrest 7 (16.3) 19 (14.8) 0.82 26 (15.2)
Ejection fraction,  
mean (SD)
41.1 (17.3) 35.4 (13.7) 0.03 36.8 (14.8)
Atrial fibrillation 12 (27.9) 43 (33.6) 0.49 55 (32.2)
Hypertension 16 (37.2) 61 (47.7) 0.24 77 (45.0)
Diabetes mellitus 7 (16.3) 43 (33.6) 0.03 50 (29.2)
Urgent inpatient 23 (53.5) 49 (38.3) 0.08 72 (42.1)
Social health indicators
 Married or common 
law
23 (53.5) 101 (78.9) 0.001 124 (72.5)
 Employed 21 (48.8) 49 (38.3) 0.23 70 (40.9)
 Lives alone 14 (32.6) 22 (17.2) 0.03 36 (21.1)
All characteristics except age were self-reported. Percentages rounded 
to first decimal place; may not add to 100% because of rounding. NYHA 
indicates New York Heart Association functional class.
*Does not sum to 100% because of exclusion of negative reports. No
imputation performed.
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SF-36v2 role emotional; the separated, divorced, or widowed 
participants exhibited the lowest scores during the entire 
course of follow-up, and the single participants achieved the 
greatest gains in their scores, over time. Indication for implan-
tation was not a predictor of individual trajectories.
Discussion
The study was limited by the moderate sample size and number 
of measurement occasions; thus, the reader is cautioned to inter-
pret the analyses within the context of this significant limitation. 
It was, in part, for this reason that we chose a statistical signifi-
cance level of 0.10 to identify the remaining residual variance. 
We lacked information about potentially important patient char-
acteristics, such as race and ethnicity, clinician-reported and 
longer-term shock history, and previous cardiac treatment (eg, 
previous pacemaker). The study would have been strengthened 
by having data that could have determined the temporal change 
trajectories beyond the 6 months studied. The selection of the 
early recovery period reflected a clinical interest to guide prac-
tice and processes of care at the healthcare center, but was likely 
Table 2. Grouped Data: Descriptive Statistics and Change in Social Health Status
Baseline At 1 mo At 2 mo At 6 mo
Absolute Mean 
Difference*
Relative Mean 
Difference 
(%)†
Relative Mean 
Difference (SD)‡
SF-36v2 role physical§
 n 171 149 140 139
 Mean 44.8 43.3 54.3 60.6 15.8 35.3 0.52
 SD 30.3 28.6 29.4 28.8
 Median 43.8 43.8 56.3 62.5
SF-36v2 role emotional║
 n 171 149 140 139
 Mean 62.8 65.6 72.9 70.1 7.3 11.6 0.23
 SD 31.8 30.4 28.6 30.3
 Median 66.7 75.0 83.3 83.3
SF-36v2 social functioning¶
 n 171 149 140 139
 Mean 60.3 66.1 73.6 74.6 14.3 23.7 0.48
 SD 29.7 26.7 28.7 27.2
 Median 62.5 75.0 87.5 75.0
Satisfaction with participation in social roles#
 n 171 149 140 139
 Mean 49.3 55.5 61.8 65.7 16.4 33.3 0.58
 SD 28.4 28.9 29.1 27.4
 Median 50.0 57.1 69.6 71.4
Satisfaction with participation in discretionary social activities**
 n 171 149 140 139
 Mean 50.7 57.4 60.7 62.6 11.9 23.5 0.39
 SD 30.2 29.3 28.5 28.6
 Median 50.0 60.7 64.3 67.9
Patient acceptance of implantable cardiac device therapy‡‡
 n 149 140 139
 Mean 69.6 74.9 74.4 4.8 6.9 0.27
 SD 17.7 18.5 18.7
 Median 70.8 78.1 77.1
*The difference in mean between the 6-month follow-up measure and baseline (ie, mean
(6 mo)
−mean
(baseline)
).
†The difference in mean between the 6-month follow-up measure and baseline, relative to the baseline, presented 
as a percentage (ie, mean
(6 mo)
−mean
(baseline)
/mean
(baseline)
×100).
‡The absolute mean difference divided by the SD observed at baseline (ie, mean
(6 mo)
−mean
(baseline)
/SD 
(baseline)
).
§Original item scaling 1 to 5; 4 items; Original score scale: 4 to 20.
║Original item scaling 1 to 5; 3 items; Original score scale: 3 to 15.
¶Original item scaling 1 to 5; 2 items; Original score scale: 2 to 10.
#Original item scaling 1 to 5; 7 items; Original score scale: 7 to 35.
**Original item scaling 1 to 5; 7 items; Original score scale: 7 to 35.
‡‡Original item scaling 1 to 5; 12 items; Original score scale: 12 to 60.
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the context of a permanently implanted device with lifetime 
implications related to surveillance, replacement requirements, 
and management of shock therapy. We cannot comment on 
the direction and trajectories of change identified in this study 
beyond the 6 months of follow-up.
The study contributes compelling new evidence that men 
and women differ in their trajectories of change in social 
health, both in terms of their starting points (ie, baseline 
scores) and their rates of change. The findings raise awareness 
of this aspect of people’s health that remains poorly studied in 
the ICD population. The reasons for the differences found are 
probably multifactorial.
Sex Differences
The findings reported here echo previous cross-sectional 
research, which has raised concerns about sex disparities 
inpatient-reported outcomes in people with ICDs, with women 
reporting significantly poorer physical functioning and vital-
ity,37 higher anxiety, shock-related distress, depressive 
symptoms,38,39 and difficulties in assuming social roles 
and responsibilities.40 In contrast, in a systematic review of 
research focused on the effects of sex on disparities in psy-
chological distress and QOL among patients with an ICD, 
researchers have found that sex did not significantly affect 
patient-reported outcomes in 26 of the 32 (80%) studies 
examined, leading to a conclusion that: there is insufficient 
evidence to conclude that sex per se is a major autonomous 
predictor for disparities (p. 798), and calls for caution about 
the clinical implications of the findings, further research suf-
ficiently powered to reach more definitive conclusions.41
In our study, sex differences in trajectories may, to some 
extent, be associated with other patient characteristics that 
varied by sex. These differences provide some descriptive 
information about potential explanations for the observed 
differences in sex trajectories. The equivocal findings of this 
study and others’ research may be related to many factors, 
including this study’s specific focus on social health, the tim-
ing of measurement occasions, the selection of instruments, 
or other factors, such as response shift or differential item 
functioning.
Varying Trajectories
There are many possible explanations for the reported sex dif-
ferences in social health trajectories. For example, previous 
research has highlighted that women exhibit greater catastro-
phizing tendencies, a phenomenon reported in the pain and 
psychological literature about a general catastrophic thinking 
style about medical events or somatic experiences that may 
predispose people to worse outcomes.42 Although this discus-
sion is speculative, it may shed light on how men and women 
evaluate their health status at the time of ICD implantation, 
and could inform patient teaching interventions.
Social support is an established influencing factor of patient 
outcomes. In a study of sex differences in the influence of 
social support on 1-year changes in functional status in older 
patients with heart failure, researchers found that women 
reported significantly less social support and poorer physical 
functioning at baseline, but the differences in clinically mean-
ingful functional decline abated during the course of the first 
year of their treatment for heart failure.43 This led the research-
ers to conclude that sex-directed strategies aimed at optimiz-
ing function may be of benefit in this population.
The finding in this study that sex differences abated over 
time, with men and women reporting similar outcomes at 
6 months, raises questions about the shape and direction of 
change in the longer-term recovery period and adaptation to 
living with an ICD. We do not know whether the women con-
tinued to improve at a faster rate than the men, whether the 
men and women retained similar rates of change, or whether 
the men significantly worsened in the longer term. In particu-
lar, it may be worrisome to note the shape of the men’s social 
health trajectories, and to speculate that they experienced 
a slower and possibly decelerating pattern of longer-term 
change. There is currently no research that has sufficiently 
addressed this question.
Figure 2. Sex-based trajectories of temporal change in social 
health (mean scores and 95% confidence intervals).
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A Faster Rate of Recovery
Recovery is inevitably influenced by biological (eg, sex) and 
social (eg, sex) factors. To date, the limited research avail-
able on sex differences has highlighted that although sud-
den cardiac death is less prevalent in women, at all ages, and 
occurs, on average, 10 years later in women than in men,44 
women with ICDs generally experience more anxiety and 
poorer QOL than do men. However, many of these studies 
have been inconclusive about the effects of sex.41 The different 
trajectories of change identified in this study are congruent 
with research about other health conditions, which describes 
women’s faster rates of recovery. For example, after standard 
knee arthroplasty, and in spite of greater functional limitations 
at the time of surgery, women were found to recover faster, 
gained better joint function, and experienced less pain in the 
early recovery period, compared with men.45 Similarly, in a 
study of sex differences in the rate of fatigue development 
and recovery after musculoskeletal injury in the workplace, 
Figure 3. Absolute mean difference in social health 
status of men compared with women at baseline 
and 6-month follow-up (95% confidence intervals). 
PROMIS indicates Patient-Reported Outcomes 
Measurement Information System.
Table 3. Absolute and Relative Mean Differences in Social Health Status of Men and Women between Baseline and 6-Month 
Follow-Up
Difference Between Baseline 
and 6 Mo Scores for Men
Difference Between Baseline 
and 6 Mo Scores for Women
Difference Between Men and 
Women at Baseline
Difference Between Men and 
Women at 6 Months
Absolute Mean 
Difference 
(Points)*
Relative Mean 
Difference 
(%)†
Absolute Mean 
Difference 
(Points)*
Relative Mean 
Difference 
(%)†
Absolute Mean 
Difference 
(Points)‡
Relative Mean 
Difference 
(%)§
Absolute Mean 
Difference 
(Points)║
Relative Mean 
Difference (%)¶
SF-36v2 social functioning 10.2 16.1 21.3 37.8 7.0 11.0 −4.1 −5.6
Satisfaction with 
participation in social roles
11.6 21.8 23.9 53.8 8.9 16.7 −3.4 −5.2
Satisfaction with 
participation in discretionary 
social activities
8.1 15.1 20.5 46.4 9.6 17.8 −2.8 −4.5
*Absolute mean difference between baseline and 6-month scores for men or women is defined as the difference in mean between the 6-month follow-up measure
and baseline (ie, mean
(6 months)
−mean
(baseline)
).
†Relative mean difference between baseline and 6 months scores for men or women as a percentage is defined as the difference in mean between the 6-month 
follow-up measure and baseline, relative to the baseline, presented as a percentage (ie, mean
(6 months)
−mean
(baseline)
/mean
(baseline)
×100).
‡Absolute mean difference in mean between men and women at baseline is defined as the difference in mean between men and women at baseline 
(ie, mean
(men at baseline)
−mean
(women at baseline)
).
§Relative mean difference between men and women at baseline as a percentage is defined as the difference in mean between men and women at baseline, relative 
to men’s scores, presented as a percentage (ie, mean
(men at baseline)
−mean
(women at baseline)
/mean
(men at baseline)
×100).
║Absolute mean difference in mean between men and women at 6 months is defined as the difference in mean between men and women at 6 months 
(ie, mean
(men at 6 months)
−mean
(women at 6 months)
).
¶Relative mean difference between men and women at 6 months as a percentage is defined as the difference in mean between men and women at 6 months, relative 
to men’s scores, presented as a percentage (ie, mean
(men at 6 months)
−mean
(women at 6 months)
/mean
(men at 6 months)
×100).
9Albert46 found that men experienced a greater relative loss of 
muscle strength, a higher rate of fatigue development, and a 
reduced capacity to maintain fatiguing contractions in their 
lower limbs, compared with women, thus decreasing their 
physical capacity and slowing their recovery. The reasons for 
these differences are currently not known, and more research 
is required to understand the mechanisms underpinning the 
different trajectories.
Conclusions
The ICD is a well-established protective device that augments 
the medical management of varying cardiac conditions by 
reducing the risk of mortality from sudden cardiac death. The 
permanency of the device and its implications on daily living 
can affect people’s physical and emotional ability to resume 
their social roles, function, and activities. We found that the 
implantation of an ICD resulted in clinically important dif-
ferences in the trajectory of men and women’s social health 
during the initial 6-month recovery period.
We cautiously conclude that the findings of the study 
highlight important knowledge that warrants consideration 
in clinical practice. The implantation of the ICD is routinely 
preceded and followed by multidisciplinary interactions with 
patients focused on patient and family education, decision sup-
port, consent, discharge guidelines, and follow-up. The aware-
ness of the overall improvement in social health over time, and 
the different trajectories experienced by men and women can 
enhance communication strategies. The findings may further 
inform the development of multidisciplinary interventions in 
the early recovery period to address alterations in social health, 
and improve overall outcomes and patients’ QOL. In particu-
lar, the effects of shock on social health warrant investigation. 
Further research must be undertaken on the social components 
of health and differences between men’s and women’s trajec-
tories of change before the association between sex and QOL 
in people with ICDs is more clearly understood.
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